1. Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering
   Camille M. Le Gall et al, 2021, Bioconjugate Chemistry CrossRef
2. Effect of neoadjuvant chemotherapy and its correlation with HPV status, EGFR, Her-2-neu, and GADD45 expression in oral squamous cell carcinoma
   Manoj Pandey et al, 2018, World Journal of Surgical Oncology CrossRef
3. Tumor microenvironment-responsive docetaxel-loaded micelle combats metastatic breast cancer
   Tianqun Lang et al, 2019, Science Bulletin CrossRef
4. The Acute Toxicities and Efficacy of Concurrent Chemotherapy With Docetaxel Plus Cisplatin, or Docetaxel, or Cisplatin and Helical Tomotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Single-Center Phase II Trial
   Yanrong Luo et al, 2022, Technology in Cancer Research & Treatment CrossRef
5. Combined Therapy for the Treatment of Cancer
   Iago Dillion Lima Cavalcanti, 2022, Chemotherapy Protocols and Infusion Sequence CrossRef
6. Tumor Cells-Selective Bionic Nanodevice Exploiting Heparanase Combats Metastatic Breast Cancer
   Tianqun Lang et al, 2018, Advanced Functional Materials CrossRef
7. Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer
   Xuejian Wang et al, 2022, Drug Resistance Updates CrossRef
8. Evaluation of a docetaxel-cisplatin-fluorouracil-Au complex in human oral carcinoma cell line
   Wannisa Khamaikawin et al, 2023, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
9. Reactive oxygen species in cancer stem cells of head and neck squamous cancer
   Xu Qian et al, 2018, Seminars in Cancer Biology CrossRef
10. pN status predicts outcomes in surgically treated pT1–pT2 patients of various disease stages with squamous cell carcinoma of the head and neck: a 17-year retrospective single center cohort study
    Xu Qian et al, 2018, European Archives of Oto-Rhino-Laryngology CrossRef
11. Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis
    Yue Dong et al, 2017, PLOS ONE CrossRef
12. Assessment of a Nano-Docetaxel Combined Treatment for Head and Neck Cancer
    Gee Young Lee et al, 2021, Onco CrossRef
13. Predictive Biomarkers for Response and Toxicity of Induction Chemotherapy in Head and Neck Cancers
    Łukasz Boguszewicz, 2022, Frontiers in Oncology CrossRef
14. Capecitabine—A “Permanent Mission” in Head and Neck Cancers “War Council”?
    Camil Ciprian Mireștean et al, 2022, Journal of Clinical Medicine CrossRef
15. Platelet-lymphocyte and neutrophil-lymphocyte ratios
    Yu-Hsi Liu et al, 2019, Journal of the Chinese Medical Association CrossRef
16. Molecular response to induction chemotherapy and its correlation with treatment outcome in head and neck cancer patients by means of NMR-based metabolomics
    Łukasz Boguszewicz et al, 2021, BMC Cancer CrossRef